Wednesday, June 10, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “modified”

433 pharma patents match "modified" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 433
Index total 30,257
Page 10 / 19

Quick answer

This filtered view shows 433 pharmaceutical patents matching "modified" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

433 results for “modified” · 30,257 patents in full index Clear search

  1. US 9856467

    Modified factor X polypeptides and uses thereof

    Catalyst Biosciences, Inc. · Granted Jan 2, 2018 · Expires Dec 28, 2037

    granted

  2. US 9855278

    Modified release preparations containing oxcarbazepine and derivatives thereof

    Supernus Pharmaceuticals, Inc. · Granted Jan 2, 2018 · Expires Dec 28, 2037

    granted

  3. US 9840493

    Modified amino acids comprising tetrazine functional groups, methods of preparation, and methods of their use

    Sutro Biopharma, Inc. · Granted Dec 12, 2017 · Expires Dec 7, 2037

    granted

  4. US 9834597

    Modified FC polypeptides, FC conjugates, and methods of use thereof

    The Regents of the University of California · Granted Dec 5, 2017 · Expires Nov 30, 2037

    granted

  5. US 9827202

    Hot-melt extrusion of modified release multi-particulates

    The Board of Regents of the University of Texas System · Granted Nov 28, 2017 · Expires Nov 23, 2037

    granted

  6. US 9828410

    β-D-2′-deoxy-2′-α-fluoro-2′-β-C-substituted-2-modified-N6-substituted purine nucleotides for HCV treatment

    Atea Pharmaceuticals, Inc. · Granted Nov 28, 2017 · Expires Nov 23, 2037

    granted

  7. US 9796974

    Modified RNAi agents

    Alnylam Pharmaceuticals, Inc. · Granted Oct 24, 2017 · Expires Oct 19, 2037

    granted

  8. US 9795655

    Modified MT-SP1 proteases that inhibit complement activation

    Catalyst Biosciences, Inc. · Granted Oct 24, 2017 · Expires Oct 19, 2037

    granted

  9. US 9789180

    D-amino acid derivative-modified peptidoglycan and methods of use thereof

    The Regents of the University of California · Granted Oct 17, 2017 · Expires Oct 12, 2037

    granted

  10. US 9790499

    Functionally-modified oligonucleotides and subunits thereof

    Sarepta Therapeutics, Inc. · Granted Oct 17, 2017 · Expires Oct 12, 2037

    granted

  11. US 9732161

    Modified Fc proteins comprising site-specific non-natural amino acid residues, conjugates of the same, methods of their preparation and methods of their use

    Sutro Biopharma, Inc. · Granted Aug 15, 2017 · Expires Aug 10, 2037

    granted

  12. US 9708386

    Modified chimeric polypeptides with improved pharmacokinetic properties

    REGENERON PHARMACEUTICALS, INC. · Granted Jul 18, 2017 · Expires Jul 13, 2037

    granted

  13. US 9707283

    Genetically modified babesia parasites expressing protective tick antigens and uses thereof

    The United States of America, as represented by the Secretary of Agriculture · Granted Jul 18, 2017 · Expires Jul 13, 2037

    granted

  14. US 9708610

    Compositions comprising alternating 2′-modified nucleosides for use in gene modulation

    Ionis Pharmaceuticals, Inc. · Granted Jul 18, 2017 · Expires Jul 13, 2037

    granted

  15. US 9700025

    Genetically modified major histocompatibility complex animals

    REGENERON PHARMACEUTICALS, INC. · Granted Jul 11, 2017 · Expires Jul 6, 2037

    granted

  16. US 9682934

    Modified amino acids

    Sutro Biopharma, Inc. · Granted Jun 20, 2017 · Expires Jun 15, 2037

    granted

  17. US 9677052

    Modified lipopolysaccharide glycoform and method of use

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Jun 13, 2017 · Expires Jun 8, 2037

    granted

  18. US 9670506

    Modified immunization vectors

    THE ARIZONA BOARD OF REGENTS · Granted Jun 6, 2017 · Expires Jun 1, 2037

    granted

  19. US 9673409

    Phosphorescent tetradentate metal complexes having modified emission spectra

    ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Jun 6, 2017 · Expires Jun 1, 2037

    granted

  20. US 9642916

    Porphyrin modified telodendrimers

    The Regents of the University of California · Granted May 9, 2017 · Expires May 4, 2037

    granted

  21. US 9644039

    Acid-degradable and bioerodible modified polyhydroxylated materials

    The Regents of the University of California · Granted May 9, 2017 · Expires May 4, 2037

    granted

  22. US 9603829

    HSP90 inhibitors with modified toxicity

    The Regents of the University of Colorado, a Body Corporate · Granted Mar 28, 2017 · Expires Mar 23, 2037

    granted

  23. US 9555159

    Inorganically surface-modified polymers and methods for making and using them

    The Regents of the University of California · Granted Jan 31, 2017 · Expires Jan 26, 2037

    granted

  24. US 9554563

    Genetically modified mice and engraftment

    REGENERON PHARMACEUTICALS, INC. · Granted Jan 31, 2017 · Expires Jan 26, 2037

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.